Recursion Pharmaceuticals applies computer vision and machine learning to create a high-dimensional feature space in which to evaluate cellular health broadly across hundreds of disease states. The talk will offer a technical overview of how Recursion leverages cellular phenotyping for drug discovery, including a brief history of the development and emergence of cellular morphological profiling and a description of the principles supporting the ability to turn a biological question of interest into a data science problem.